Cue Biopharma
89 hedge funds and large institutions have $246M invested in Cue Biopharma in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 30 increasing their positions, 30 reducing their positions, and 5 closing their positions.
Holders
89
Holders Change
–
Holders Change %
0%
% of All Funds
1.56%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
5
Increased
30
Reduced
30
Closed
5
Calls
$1.73M
Puts
$745K
Net Calls
+$980K
Net Calls Change
+$1.85M
Top Buyers
Top Sellers
| 1 |
CA
1
Corriente Advisors
Fort Worth,
Texas
|
$13.8M |
| 2 |
WP
2
Woodline Partners
San Francisco,
California
|
$4.15M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$19M |
| 4 |
4
Goldman Sachs
New York
|
$3.42M |
| 5 |
5
Millennium Management
New York
|
$1.2M |
